Stay updated on Crizotinib in ALK, MET, ROS1 Alterations Clinical Trial
Sign up to get notified when there's something new on the Crizotinib in ALK, MET, ROS1 Alterations Clinical Trial page.

Latest updates to the Crizotinib in ALK, MET, ROS1 Alterations Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedA new Revision: v3.3.3 entry was added to the history and references to HHS Vulnerability Disclosure and Revision: v3.3.2 were removed. This appears to be a routine maintenance update and does not alter the study record content.SummaryDifference0.2%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedThe Record History shows a new revision entry v3.3.2 and removes v3.3.1, a minor version-label change. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check48 days agoChange DetectedNew revision label added: Revision: v3.3.1, replacing the previous v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check55 days agoChange DetectedThe government funding notice was removed from the page history; core study details and records remain the same.SummaryDifference0.7%

- Check69 days agoChange DetectedThe old and new screenshots show the same page content with no substantive updates to study details, status, or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check98 days agoChange DetectedAdded a government-operating-status notice and a version upgrade to v3.2.0; removed the previous v3.1.0 marker.SummaryDifference12%

Stay in the know with updates to Crizotinib in ALK, MET, ROS1 Alterations Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Crizotinib in ALK, MET, ROS1 Alterations Clinical Trial page.